Literature DB >> 2030744

Role of adenosine in functional hyperemia in skeletal muscle as indicated by pharmacological tools.

M G Persson1, A Ohlén, L Lindbom, P Hedqvist, L E Gustafsson.   

Abstract

The hypothesis that adenosine mediates blood flow increments in contracting skeletal muscle was evaluated by intravital microscopy of the microcirculation in the tenuissimus muscle of anesthetized rabbits. Motor nerve stimulation elicited muscle contractions and frequency-dependent arteriolar dilatation, particularly in terminal arterioles. The pulse duration (0.05 ms) and voltage (1.5-5 V) precluded activation of vasoconstrictor fibers, as also indicated by the lack of effect of phentolamine on resting vascular tone and on the hyperemic response to nerve stimulation. The specific adenosine receptor antagonist, 1,3-dipropyl-8-p-sulfo-phenylxanthine (DPSPX; 10(-5) M), attenuated the hyperemic response to muscle contractions. The adenosine uptake inhibitor dipyridamole (10(-8)-10(-6) M) dose-dependently dilated microvessels, an effect prevented by DPSPX (10(-5) M). Moreover, dipyridamole (10(-7) M) augmented contraction-induced hyperemia. The enhancement by dipyridamole was reversed by DPSPX (10(-5) M). The effects of adenosine uptake inhibitor and antagonist were invariably more marked in terminal than in transverse arterioles, and also more pronounced at higher stimulation frequencies. Motor nerve stimulation failed to induce alterations in vascular diameters when the neuromuscular junction was blocked by pancuronium. Thus, our observations indicate that functional hyperemia after motor nerve-induced contractions of the skeletal muscle was of postjunctional origin. Apparently, activation of adenosine receptors was responsible for a part of the evoked vasodilation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2030744     DOI: 10.1007/bf00180676

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  ROLE OF CHEMICAL FACTORS IN REGULATION OF FLOW THROUGH KIDNEY, HINDLIMB, AND HEART.

Authors:  J B SCOTT; R M DAUGHERTY; J M DABNEY; F J HADDY
Journal:  Am J Physiol       Date:  1965-05

2.  Redistribution of coronary microvascular resistance produced by dipyridamole.

Authors:  W M Chilian; S M Layne; E C Klausner; C L Eastham; M L Marcus
Journal:  Am J Physiol       Date:  1989-02

3.  The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices.

Authors:  A Sattin; T W Rall
Journal:  Mol Pharmacol       Date:  1970-01       Impact factor: 4.436

4.  Adenosine and adenine nucleotides as possible mediators of cardiac and skeletal muscle blood flow regulation.

Authors:  R M Berne; R Rubio; J G Dobson; R R Curnish
Journal:  Circ Res       Date:  1971-01       Impact factor: 17.367

5.  Adenosine and active hyperemia in dog skeletal muscle.

Authors:  E L Bockman; R M Berne; R Rubio
Journal:  Am J Physiol       Date:  1976-06

6.  Reduction of exercise dilation by theophylline.

Authors:  H M Tabaie; J B Scott; F J Haddy
Journal:  Proc Soc Exp Biol Med       Date:  1977-01

7.  Non-homogeneous blood flow distribution in the rabbit tenuissimus muscle. Differential control of total blood flow and capillary perfusion.

Authors:  L Lindbom; K E Arfors
Journal:  Acta Physiol Scand       Date:  1984-11

8.  Adenosine modulation of resting vascular tone in rabbit skeletal muscle.

Authors:  L E Gustafsson; M G Persson; A Ohlén; P Hedqvist; L Lindbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

9.  Conditions for dipyridamole potentiation of skeletal muscle active hyperemia.

Authors:  R E Klabunde
Journal:  Am J Physiol       Date:  1986-01

10.  Adenosine content of skeletal muscle during active hyperemia and ischemic contraction.

Authors:  R D Phair; H V Sparks
Journal:  Am J Physiol       Date:  1979-07
View more
  6 in total

Review 1.  Local control of skeletal muscle blood flow during exercise: influence of available oxygen.

Authors:  Darren P Casey; Michael J Joyner
Journal:  J Appl Physiol (1985)       Date:  2011-09-01

2.  Contribution of nitric oxide to exercise-induced hypotension in human sympathetic denervation.

Authors:  A B Akinola; J M Land; C J Mathias; G Giovannoni; F Magnifico; S Puvi-Rajasingham; G D Smith; L Watson
Journal:  Clin Auton Res       Date:  1999-10       Impact factor: 4.435

3.  Contribution of adenosine to compensatory dilation in hypoperfused contracting human muscles is independent of nitric oxide.

Authors:  Darren P Casey; Michael J Joyner
Journal:  J Appl Physiol (1985)       Date:  2011-02-03

4.  Adenosine transporter antagonism in humans augments vasodilator responsiveness to adenosine, but not exercise, in both adenosine responders and non-responders.

Authors:  Elizabeth A Martin; Wayne T Nicholson; Timothy B Curry; John H Eisenach; Nisha Charkoudian; Michael J Joyner
Journal:  J Physiol       Date:  2006-12-07       Impact factor: 5.182

Review 5.  Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review.

Authors:  Andréia Machado Cardoso; Mauro Nicollas Oliveira Silvério; Sarah Franco Vieira de Oliveira Maciel
Journal:  Purinergic Signal       Date:  2021-09-29       Impact factor: 3.765

6.  Enhanced sympathetic neurotransmission in the tail artery of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX)-treated rats.

Authors:  P Karoon; A Rubino; G Burnstock
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.